Hagan, Norway

Steinar Hagen



Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hagen, NO (2003)
  • Hagan, NO (2002 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Steinar Hagen: Innovator in Pharmaceutical Chemistry**

Introduction

Steinar Hagen, based in Hagan, Norway, is a notable inventor known for his contributions to pharmaceutical chemistry, particularly in the development of innovative treatments for various cancers. With a portfolio of four patents to his name, Hagen’s work focuses on utilizing fatty acid derivatives and dioxolane compounds as therapeutic agents.

Latest Patents

One of Hagen's latest patents, titled "Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents," explores the use of certain unsaturated fatty acid derivatives of glucocorticoids. This invention aims to develop pharmaceutical formulations that exhibit anti-inflammatory and anti-cancer properties.

Another significant patent from his portfolio is "Dioxolane derivatives for the treatment of cancer." This invention addresses unsaturated fatty acid derivatives of 1,3-dioxolane nucleoside analogues and their use in treating various types of cancer, including solid tumors and hematological cancers such as leukemias, lymphomas, and multiple myelomas. The compounds involved fall within a specific formula, highlighting Hagen's commitment to advancing cancer therapies.

Career Highlights

Steinar Hagen has collaborated with esteemed companies in the pharmaceutical sector, including Clavis Pharma ASA and Amersham Pharmacia Biotech AB. Throughout his career, he has focused on groundbreaking research that emphasizes the therapeutic benefits of his innovative compounds.

Collaborations

In his professional journey, Hagen has worked alongside accomplished colleagues, including Finn Myhren and Marit Liland Sandvold. Their collaborative efforts have contributed to advancing research and development in the field of oncology.

Conclusion

Steinar Hagen's inventive spirit and dedication to innovating treatments for cancer position him as a significant figure in pharmaceutical research. His patented works reflect a commitment to improving patient outcomes through novel pharmacological solutions. As he continues to explore the intersection of chemistry and medicine, his contributions are sure to impact the healthcare landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…